Treatment of the cardiac-impaired depressed patient. Part II: Lithium, carbamazepine, and electroconvulsive therapy.
Guttmacher
L B
LB
University of Rochester School of Medicine and Dentistry, New York.
Goldstein
M G
MG
D001145:Arrhythmias, Cardiac / Q000209:etiology*; D002220:Carbamazepine / Q000009:adverse effects* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003866:Depressive Disorder / Q000523:psychology / Q000628:therapy*; D004565:Electroconvulsive Therapy / Q000009:adverse effects*; D006331:Heart Diseases / Q000523:psychology*; D006801:Humans; D008094:Lithium / Q000009:adverse effects* / Q000627:therapeutic use; D012307:Risk Factors
D002220:Carbamazepine; D008094:Lithium